Application Nr Approved Date Route Status External Links
BLA125696 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Palforzia Is An Oral Immunotherapy Indicated For The Mitigation Of Allergic Reactions, Including Anaphylaxis, That May Occur With Accidental Exposure To Peanut. Palforzia Is Approved For Use In Patients With A Confirmed Diagnosis Of Peanut Allergy. Initial Dose Escalation May Be Administered To Patients Aged 4 Through 17 Years. Up-Dosing And Maintenance May Be Continued In Patients 4 Years Of Age And Older [See Dosage And Administration (2.4) ] . Palforzia Is To Be Used In Conjunction With A Peanut-Avoidant Diet. Palforzia Is An Oral Immunotherapy Indicated For The Mitigation Of Allergic Reactions, Including Anaphylaxis, That May Occur With Accidental Exposure To Peanut. Palforzia Is Approved For Use In Patients With A Confirmed Diagnosis Of Peanut Allergy. Initial Dose Escalation May Be Administered To Patients Aged 4 Through 17 Years. Up-Dosing And Maintenance May Be Continued In Patients 4 Years Of Age And Older ( 2.4 ). Palforzia Is To Be Used In Conjunction With A Peanut-Avoidant Diet. Limitation Of Use: Not Indicated For The Emergency Treatment Of Allergic Reactions, Including Anaphylaxis. Limitation Of Use: Not Indicated For The Emergency Treatment Of Allergic Reactions, Including Anaphylaxis.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Peanut

Comments